One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133<sup>+</sup> Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction

<table>Flow chart of the COMAPRE-AMI trial. MI indicates myocardial infarction, PCI percutaneous coronary intervention, LVEF left ventricular ejection fraction, IC intracoronary, LV left ventricle, IVUS, intravascular ultrasound, FFR fractional flow reserve, PET positron emission tomography, MIBI technetium 99 m sestamibi,  MRI magnetic resonance imaging, and ECG electrocardiogram.</table>

Bone Marrow Research

fig1

Figure 1

Figure 1: One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133<sup>+</sup> Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction 

Figure 1 | One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction 